scholarly journals Long-term effects of risperidoneversushaloperidol on verbal memory, attention, and symptomatology in schizophrenia

2007 ◽  
Vol 14 (1) ◽  
pp. 110-118 ◽  
Author(s):  
SOPHIE RÉMILLARD ◽  
EMMANUELLE POURCHER ◽  
HENRI COHEN
Keyword(s):  
Verbal Memory ◽  
Negative Symptoms ◽  
Psychiatric Symptoms ◽  
Verbal Learning ◽  
California Verbal Learning Test ◽  
Neurocognitive Performance ◽  
Long Term Effects ◽  
Assessment Period ◽  
Learning Test

There is evidence in the literature that cognitive functions in schizophrenia (SC) may be improved by atypical neuroleptics (NLPs) in contrast to typical medication, but there is still controversy regarding this apparent superiority of atypical drugs. In this study, we assessed the differential effects of risperidone and haloperidol on verbal memory, attention, and psychiatric symptoms in SC. The performance of 28 SC participants, randomly assigned to risperidone (2–6 mg/day) or haloperidol (2–40 mg/day), was compared with that of healthy controls. The California Verbal Learning Test (CVLT), the d2 Cancellation Test, and the Positive and Negative Symptoms Scale were administered at baseline and 3, 6, and 12 months. Relative to controls, all SC participants showed markedly impaired verbal memory and processing speed at each assessment period. There was no differential effect between the two NLPs on CVLT and d2 performance. However, risperidone was more effective than haloperidol in reducing psychiatric symptoms. Improvement in symptom severity was not associated with improvement in neurocognitive performance on these specific tests. Neither conventional nor atypical neuroleptic medications improved neurocognitive functioning over a 12-month follow-up, suggesting that psychopathological improvement under risperidone is independent of cognitive function. (JINS, 2008,14, 110–118.)

scholarly journals Remote assessment of verbal memory in MS patients using the California Verbal Learning Test

2017 ◽  
Vol 24 (3) ◽  
pp. 354-357 ◽  
Author(s):  
Lisa F Barcellos ◽  
Kalliope H Bellesis ◽  
Ling Shen ◽  
Xiaorong Shao ◽  
Terrence Chinn ◽  
...  
Keyword(s):  
Verbal Memory ◽  
Cognitive Assessment ◽  
Verbal Learning ◽  
California Verbal Learning Test ◽  
Healthy Controls ◽  
Factor Analyses ◽  
Assessment Protocol ◽  
Remote Assessment ◽  
Patient Groups ◽  
Learning Test

We used the California Verbal Learning Test, Second Edition (CVLT-II), one component of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), to determine feasibility of a remote assessment protocol. We compared telephone-administered CVLT-II data from MS patients to data acquired in person from an independent sample of patients and healthy controls. Mixed factor analyses of variance (ANOVAs) showed no significant differences between patient groups, but between-group effects comparing patients and healthy controls were significant. In this study, CVLT-II assessment by conventional in-person and remote telephone assessment yielded indistinguishable results. The findings indicate that telephone-administered CVLT-II is feasible. Further validation studies are underway.

scholarly journals A-182 Convergent and Divergent Validity of the ChAMP with the CVLT-C and RCFT in Children with Epilepsy

2020 ◽  
Vol 35 (6) ◽  
pp. 977-977
Author(s):  
David C ◽  
Brooks B ◽  
Macallister W
Keyword(s):  
Verbal Memory ◽  
Visual Memory ◽  
Verbal Learning ◽  
California Verbal Learning Test ◽  
Divergent Validity ◽  
Complex Figure ◽  
Visual Tasks ◽  
Convergent And Divergent Validity ◽  
Learning Test ◽  
Figure Test

Abstract Objective As new measures of memory become available, clinicians may be cautious to adopt them without evidence supporting their validity. The present study assesses the convergent and divergent validity of the Child and Adolescent Memory Profile (ChAMP), with the California Verbal Learning Test Children’s (CVLT-C) and the Rey Complex Figure Test (RCFT) in children with epilepsy. Method Twenty four clinically referred children (16 female, 8 male, - age = 12.37 years, SD = 2.68) completed the ChAMP, CVLT-C, and RCFT. Pearson correlations assessed the ChAMP’s convergent and divergent validity with the CVLT-C and the RCFT. Base rate of impairment was calculated for scores ≤2nd percentile. Results The ChAMP verbal tasks demonstrated strong relations with CVLT-C (lists; r = 0.678 p = < .001, instructions; r = 0.724 p = < .001 with CVLT-C learning trials and ChAMP lists free recall with CVLT-C long delay r = 0.580 p = .003). The ChAMP visual tasks correlated strongly with the RCFT delay (objects; r = 0.570 p = .004, places; r = 0.619 p = .001, Visual Memory Index; r = 0.657 p = < .001). However, divergent validity was limited as ChAMP Verbal Memory Index correlated with RCFT delay (r = 0.550 p = .005) and ChAMP Visual Memory Index with CVLT-C delay (r = 0.606 p = .002). Eight percent were deemed impaired on ChAMP lists delay similar to the CVLT-C delay (13%), however, ChAMP places delay identified 21% impaired, compared to the RCFT delay (42%). Conclusions ChAMP scores are strongly correlated with older established measures, but identify fewer cases as clinically impaired. This may reflect the more contemporary normative data or the fact that ChAMP tasks are less multifactorial in nature than are the CVLT-C and RCFT.

Identification of Subtle Verbal Memory Deficits in Premanifest Huntington Disease Using the California Verbal Learning Test

2020 ◽  
Vol 33 (1) ◽  
pp. 16-22 ◽  
Author(s):  
Heather M. Holden ◽  
Savanna M. Tierney ◽  
Lisa V. Graves ◽  
Ilex Beltran-Najera ◽  
Steven Paul Woods ◽  
...  
Keyword(s):  
Huntington Disease ◽  
Verbal Memory ◽  
Verbal Learning ◽  
Memory Deficits ◽  
California Verbal Learning Test ◽  
Learning Test

scholarly journals Long-term test-retest reliability of the California Verbal Learning Test – second edition

2017 ◽  
Vol 31 (8) ◽  
pp. 1449-1458 ◽  
Author(s):  
Andrea G. Alioto ◽  
Joel H. Kramer ◽  
Sarah Borish ◽  
John Neuhaus ◽  
Rowan Saloner ◽  
...  
Keyword(s):  
Verbal Learning ◽  
California Verbal Learning Test ◽  
Retest Reliability ◽  
Learning Test ◽  
Test Retest Reliability

Proactive inhibition and semantic organization Relationship with verbal memory in patients with schizophrenia

1996 ◽  
Vol 2 (6) ◽  
pp. 486-493 ◽  
Author(s):  
David A. Kareken ◽  
Paul J. Moberg ◽  
Ruben C. Gur
Keyword(s):  
Verbal Memory ◽  
Semantic Processing ◽  
Verbal Learning ◽  
Semantic Category ◽  
Semantic Content ◽  
Proactive Inhibition ◽  
California Verbal Learning Test ◽  
Retroactive Inhibition ◽  
Intrusion Errors ◽  
Learning Test

AbstractCompared to other cognitive functions in schizophrenia, evidence suggests that verbal memory is particularly impaired. This study used the California Verbal Learning Test (CVLT) to examine proactive inhibition (PI) and semantic processing in verbal memory in 29 patients with schizophrenia and 29 healthy controls. Patients showed significantly less PI, but also did not organize (cluster) their recall according to semantic category. Controls and patients demonstrated small retroactive inhibition (RI) effects regardless of semantic content. Although both groups made similar types and numbers of free recall intrusion errors, patients committed more phonemic and nonshared recognition errors. Results suggest that reduced semantic processing prevented build of PI, and contributes to defective memory in schizophrenia. The anatomic-physiologic abnormalities that underlie these findings may be particularly pronounced in prefrontal and temporal-parietal cortical areas. (JINS, 1996, 2, 486–493.)

scholarly journals Refined Measurement of Verbal Learning and Memory: Application of Item Response Theory to California Verbal Learning Test – Second Edition (CVLT-II) Learning Trials

2019 ◽  
Vol 35 (1) ◽  
pp. 90-104 ◽  
Author(s):  
Indrani Thiruselvam ◽  
James B Hoelzle
Keyword(s):  
Item Response Theory ◽  
Item Response ◽  
Verbal Memory ◽  
Clinical Decision Making ◽  
Verbal Learning ◽  
California Verbal Learning Test ◽  
Response Theory ◽  
Memory Ability ◽  
Learning Test ◽  
Learning Trials

Abstract Objective This study was conducted to investigate how items contained within the California Verbal Learning Test – Second Edition (CVLT-II; Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (2000). California Verbal Learning Test (2nd ed.). San Antonio, TX: Psychological Corporation) learning trials function and to evaluate whether weighted scoring approaches might improve quantification of verbal memory. Method Archival data from 577 individuals (338 healthy young adults, 239 medical or psychiatric patients referred to a neuropsychology clinic) were obtained and evaluated using item response theory. Results The serial position effect was evident across trials, but was most evident in Trials 1, 2, and 3. CVLT-II Trial 5 was the most effective among the five learning trials in quantifying verbal memory, although it was most effective when measuring lower memory ability levels. In contrast, CVLT-II Trial 1 items had, on average, the highest difficulty levels. Various weighted scoring approaches did not appear incrementally helpful in improving prediction of memory performance. Conclusion Specific items and trials differentially discriminate between examinees with low levels of memory ability; it is important to thoroughly evaluate item properties of tests used in clinical decision-making.

Neurocognitive Predictors of Functioning in Schizophrenia: Five Years Follow Up Study

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
M.L. Vargas ◽  
J.C. Sanz ◽  
N. Jimeno-Bulnes ◽  
S. Lopez
Keyword(s):  
Processing Speed ◽  
Verbal Memory ◽  
Verbal Learning ◽  
Outcome Variable ◽  
California Verbal Learning Test ◽  
Linear Regression Models ◽  
Psychiatric Admission ◽  
Processing Speed Index ◽  
Learning Test

Aims:Verbal memory and processing speed are two of the proposed neurocognitive predictors in schizophrenia. the objective is to determinate neurocognitive predictors of functioning in one five years follow-up period on ambulatory schizophrenia patients.Method:We conduct one cohort study on 30 schizophrenia out-patients (19 male; age mean: 32.8 years; SD:7.2). at the moment of inclusion it was applied one neuropsychological battery sensitive to neuropsychological deficit in schizophrenia: WAIS-III, BADS, WCST, Colour Trails, Trail Making A and B, BVRT, California Verbal Learning Test (Spanish version: TAVEC). Variables was summarized determining Z values and principal components. the cohort was prospectively studied for up to five years. as result variables it were considered: time to the first antipsychotic-drug change, time to the first psychiatric admission, and average five-years annual score in the Strauss-Carpenter Outcome Scale. It was constructed Cox and Linear Regression Models to determinate the better predicting neurocognitive components.Results:The better global outcome was directly related with WAIS-III processing speed index (corrected R square: 0.19; p = 0.02; beta constant= 0.469; beta WAIS-III processing speed= 0.125). None predictor was selected for the outcome variable change of antipsychotic. Psychiatric admission was predicted (p=0.006) by implicit learning (beta= -2.19), executive functioning (beta= 1.02), WAIS-III Total IQ (beta= 0.45) and WAIS-III Perceptual Organization Index (beta= -0.20).Conclusion:Higher processing speed index predicts one better functioning outcome during five-years follow-up. the risk for psychiatric admission was heterogeneously related with neurocognitive predictors. Verbal memory did not predict functional outcome.

High Cognitive Reserve in Bipolar Disorders as a Moderator of Neurocognitive Impairment

2017 ◽  
Vol 41 (S1) ◽  
pp. S116-S116
Author(s):  
I. Grande ◽  
J. Sanchez-Moreno ◽  
B. Solé ◽  
E. Jimenez ◽  
C. Torrent ◽  
...  
Keyword(s):  
Verbal Memory ◽  
Cognitive Reserve ◽  
Verbal Learning ◽  
Clinical Manifestations ◽  
Bipolar Disorders ◽  
Cued Recall ◽  
California Verbal Learning Test ◽  
Psychotic Symptoms ◽  
Neurocognitive Performance ◽  
Carlos Iii

BackgroundCognitive reserve (CR) reflects the capacity of the brain to endure neuropathology, minimize clinical manifestations and successfully complete cognitive tasks. The present study aims to determine whether high CR may constitute a moderator of cognitive functioning in bipolar disorder (BD).MethodsOne hundred and two patients with BD and 32 healthy controls were enrolled. All patients met DSM-IV criteria for I or II BD and were euthymic (YMRS ≤ 6 and HDRS ≤ 8) during a 6-month period. All participants were tested with a comprehensive neuropsychological battery, and a Cerebral Reserve Score (CRS) was estimated. Subjects with a CRS below the group median were classified as having low CR, whereas participants with a CRS above the median value were considered to have high CR.ResultsParticipants with BD with high CR displayed a better performance in measures of attention (digits forward: F = 4.554, P = 0.039); phonemic and semantic verbal fluency (FAS: F = 9.328, P = 0.004; and Animal Naming: F = 8.532, P = 0.006); and verbal memory (short cued recall of California Verbal Learning Test: F = 4.236, P = 0.046), after multivariable adjustment for potential confounders, including number of admissions and prior psychotic symptoms.ConclusionsHigh cognitive reserve may therefore be a valuable construct to explore for predicting neurocognitive performance in patients with BD regarding premorbid status.Disclosure of interestDr. I. Grande has received a Juan Rodés Contract (JR15/00012), Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, Barcelona, Spain and has served as a consultant for Ferrer and as a speaker for AstraZeneca, Ferrer and Janssen-Cilag.Disclosure of interestDr. I. Grande has received a Juan Rodés Contract (JR15/00012), Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, Barcelona, Spain and has served as a consultant for Ferrer and as a speaker for AstraZeneca, Ferrer and Janssen-Cilag.

the Deleterious Effect of Cognitive Impairment, Negative Symptoms and Functional Disability on Quality of Life in Chronic Schizophrenia

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
E. Elizagárate ◽  
P. Sánchez ◽  
A.B. Yoller ◽  
J. Peña ◽  
N. Ojeda ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Verbal Memory ◽  
Negative Symptoms ◽  
Functional Disability ◽  
Psychiatric Symptoms ◽  
Neuropsychological Functioning ◽  
Chronic Schizophrenia ◽  
Motor Speed

Aims:To examine the relative contributions of psychiatric symptoms, functional disability, neuropsychological functioning and sociodemographic variables to quality of life (QOL) in patients with chronic schizophrenia.Method:We examined 165 hospitalised patients with long term schizophrenia (DSM-IV). Measures of psychiatric symptoms included depression (Calgary depression Scale), insight (David Insight Scale), symptom severity (BPRS) and PANSS (Positive and Negative Symptom Scale). Neuropsychological battery included tests for verbal memory, executive functioning, verbal fluency, working memory, motor speed and processing speed. Functional disability was assessed with the Disability Assessment Schedule (DAS-WHO) and Quality of life was assessed with the Quality of Life Scale.Results:Age, years of evolution, negative symptoms, insight and neuropsychological variables (except motor speed) all were significantly related to level of quality of life. in a multiple regression analysis, entering the neuropsychological functioning, functional disability and negative symptoms generated a model which accounted for a 74.9% of the variance in QOL. Functional disability, as expected, accounted for 56% of the variance, whereas Processing Speed explained an additional 6.2%. Symptom Severity and Verbal Fluency predicted 3.7% and 3.5% of the variance, respectively. Negative symptoms, Verbal Memory and Vocabulary, were also significant predictors in the model, but had less predictive value. However, Positive Symptoms and Sociodemographic Variables did not significantly contribute to predict quality of life.Conclusion:Our findings support the predictive value of neuropsychological functioning, functional disability and severity of negative symptoms in long term quality of life in schizophrenia.

Sign in / Sign up

Export Citation Format

Share Document